BAYER’S MONSANTO UNIT FILES A PROPOSED U.S. CLASS SETTLEMENT – It totals as much as $7.25 billion to resolve all roundup cancer cases
Bayer has said that its Monsanto unit had filed a proposed U.S. class settlement totalling as much as $7.25 billion that was aimed at resolving current and future claims that its Roundup weedkiller caused Non‑Hodgkins lymphoma.
The German company said the proposed nationwide settlement, filed in the Circuit Court of the City of St. Louis, Missouri, would establish a long‑term claims program funded by capped annual payments over up to 21 years.
Bayer, which has been dogged by the Roundup claims for years after buying Monsanto, said it is separately preparing additional settlements covering existing U.S. Roundup cases worth about $3 billion.
The proposed settlement will cover the majority of cases pending in both U.S. state and federal courts. The proposal will require approval by a judge.
The proposal includes a provision allowing people who can prove that they have been diagnosed with Non-Hodgkins lymphoma and were exposed to Roundup to file claims to receive a portion of the settlement for up to 21 years.
